Healthcare -
Biotechnology - NASDAQ - US
$ 6.47
-0.919 %
$ 277 M
Market Cap
-11.55
P/E
DMAC - GROSS PROFIT
Gross Profit DMAC - DiaMedica Therapeutics Inc.
-30 K
LAST VALUE
-11.80%
2 YEAR CAGR
-1.17%
5 YEAR CAGR
0.00%
10 YEAR CAGR